Swiss - Delayed Quote CHF

Santhera Pharmaceuticals Holding AG (SANN.SW)

Compare
8.80 +0.11 (+1.27%)
At close: November 7 at 5:31 PM GMT+1
Currency in CHF All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
103,414.00
103,414.00
7,473.00
-1,595.00
15,008.00
Cost of Revenue
3,235.00
3,235.00
3,592.00
3,767.00
10,431.00
Gross Profit
100,179.00
100,179.00
3,881.00
-5,362.00
4,577.00
Operating Expense
49,018.00
49,018.00
55,857.00
51,526.00
57,653.00
Operating Income
51,161.00
51,161.00
-51,976.00
-56,888.00
-53,076.00
Net Non Operating Interest Income Expense
-20,910.00
-20,910.00
-20,342.00
-19,861.00
-15,144.00
Pretax Income
54,820.00
54,820.00
-70,616.00
-54,717.00
-67,456.00
Tax Provision
38.00
38.00
460.00
809.00
203.00
Net Income Common Stockholders
54,782.00
54,782.00
-71,076.00
-55,526.00
-67,659.00
Diluted NI Available to Com Stockholders
54,782.00
54,782.00
-71,076.00
-55,526.00
-67,659.00
Basic EPS
5.18
--
-11.67
-16.20
-50.80
Diluted EPS
5.01
--
-11.67
-16.20
-50.80
Basic Average Shares
10,578.75
--
6,092.73
3,416.99
1,331.59
Diluted Average Shares
10,923.66
--
6,092.73
3,416.99
1,331.59
Total Operating Income as Reported
68,844.00
68,844.00
-51,976.00
-56,888.00
-53,076.00
Rent Expense Supplemental
--
--
165.00
190.00
16.00
Total Expenses
52,253.00
52,253.00
59,449.00
55,293.00
68,084.00
Net Income from Continuing & Discontinued Operation
54,782.00
54,782.00
-71,076.00
-55,526.00
-67,659.00
Normalized Income
29,082.83
29,082.83
-72,836.46
-74,322.22
-68,077.99
Interest Income
506.00
506.00
--
1.00
3.00
Interest Expense
21,314.00
21,314.00
20,189.00
16,423.00
6,891.00
Net Interest Income
-20,910.00
-20,910.00
-20,342.00
-19,861.00
-15,144.00
EBIT
76,134.00
76,134.00
-50,427.00
-38,294.00
-60,565.00
EBITDA
79,178.00
79,178.00
-40,569.00
-34,570.00
-53,428.00
Reconciled Cost of Revenue
3,235.00
3,235.00
3,592.00
3,767.00
10,431.00
Reconciled Depreciation
3,044.00
3,044.00
9,858.00
3,724.00
7,137.00
Net Income from Continuing Operation Net Minority Interest
54,782.00
54,782.00
-71,076.00
-55,526.00
-67,659.00
Total Unusual Items Excluding Goodwill
25,717.00
25,717.00
1,924.00
22,095.00
492.00
Total Unusual Items
25,717.00
25,717.00
1,924.00
22,095.00
492.00
Normalized EBITDA
53,461.00
53,461.00
-42,493.00
-56,665.00
-53,920.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
17.83
17.83
163.54
3,298.78
73.01
12/31/2020 - 11/3/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers